Literature DB >> 3415675

Release of immunoreactive-neuropeptide by rat platelets.

A K Myers1, M Y Farhat, C A Vaz, H R Keiser, Z Zukowska-Grojec.   

Abstract

Neuropeptide Y, a potent vasoconstrictor and cardiac depressant, is re-leased from sympathetic nerve endings. Its presence in megakaryocytes suggests this peptide might be stored in platelet granules and released during aggregation. Immunoreactive-neuropeptide Y was measured in platelet rich and platelet poor plasma, and was substantially greater in the former. Addition of collagen to platelets resulted in release of neuropeptide Y which paralleled, in a concentration-dependent manner, the degree of platelet aggregation. Adenosine diphosphate, at concentrations which induce only the first phase of aggregation and not the release reaction, caused only a minor release of neuropeptide Y. These results suggest that platelet release could be a major source of circulating neuropeptide Y and could contribute to hemodynamics of pathophysiological states involving platelet activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415675     DOI: 10.1016/s0006-291x(88)81057-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Neuropeptide Y changes the excitability of fine afferent units in the rat knee joint.

Authors:  S Just; B Heppelmann
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 2.  NPY and stress 30 years later: the peripheral view.

Authors:  Dalay Hirsch; Zofia Zukowska
Journal:  Cell Mol Neurobiol       Date:  2012-01-24       Impact factor: 5.046

3.  Autoradiographic analysis of vasoactive neuropeptide uptake by rabbit megakaryocytes and platelets.

Authors:  T Daimon
Journal:  J Anat       Date:  1991-06       Impact factor: 2.610

4.  NPY and NPY receptors in airway structural and inflammatory cells in allergic asthma.

Authors:  Toluwalope O Makinde; Robert Steininger; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2012-06-12       Impact factor: 3.362

5.  Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Puggioni; C Della Rocca; R Businaro
Journal:  Mol Cell Biochem       Date:  2014-06-06       Impact factor: 3.396

6.  Neuropeptide Y overflow and metabolism in skeletal muscle arterioles.

Authors:  Kirk W Evanson; Audrey J Stone; Allyson L Hammond; Heidi A Kluess
Journal:  J Physiol       Date:  2011-05-09       Impact factor: 5.182

7.  Of mice and men: neuropeptide Y and its receptors are associated with atherosclerotic lesion burden and vulnerability.

Authors:  Lijun Li; Amir H Najafi; Joanna B Kitlinska; Richard Neville; James Laredo; Stephen E Epstein; Mary Susan Burnett; Zofia Zukowska
Journal:  J Cardiovasc Transl Res       Date:  2011-04-06       Impact factor: 4.132

8.  Platelet neuropeptide Y is critical for ischemic revascularization in mice.

Authors:  Jason U Tilan; Lindsay M Everhart; Ken Abe; Lydia Kuo-Bonde; Dan Chalothorn; Joanna Kitlinska; Mary Susan Burnett; Stephen E Epstein; James E Faber; Zofia Zukowska
Journal:  FASEB J       Date:  2013-03-01       Impact factor: 5.191

9.  Neuropeptide Y inhibits human and invertebrate immunocyte chemotaxis, chemokinesis, and spontaneous activation.

Authors:  P Dureus; D Louis; A V Grant; T V Bilfinger; G B Stefano
Journal:  Cell Mol Neurobiol       Date:  1993-10       Impact factor: 5.046

10.  Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.

Authors:  Svati H Shah; Neil J Freedman; Lisheng Zhang; David R Crosslin; David H Stone; Carol Haynes; Jessica Johnson; Sarah Nelson; Liyong Wang; Jessica J Connelly; Michael Muehlbauer; Geoffrey S Ginsburg; David C Crossman; Christopher J H Jones; Jeffery Vance; Michael H Sketch; Christopher B Granger; Christopher B Newgard; Simon G Gregory; Pascal J Goldschmidt-Clermont; William E Kraus; Elizabeth R Hauser
Journal:  PLoS Genet       Date:  2009-01-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.